Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Health

Sponsor
Ottawa Heart Institute Research Corporation
Study ID
NCT07486986
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
48 Years - 58 Years
Healthy Volunteers
Not accepted

Interventions

  • 4 years of clinical evaluations. — OTHER
    The intervention in this study is the additional clinical evaluations for women with type 2 DM and in perimenopause.

Study Details

EMPOWER aims to determine the overall effect of menopause and sleep disruption on cardiac remodeling in women with type 2 diabetes.

Key Dates

First listed
Mar 23, 2026
Start date
Sep 30, 2026
Status verified
Jun 2026
Primary completion
Dec 31, 2032
Completion
Dec 31, 2032

Study Design

Enrollment
381 participants (estimated)

Arms

  • Arm: Evaluation
    This is a non-randomized study following individuals in perimenopause with type 2 diabetes. The population will follow a 4 evaluation/observation period with associated questionnaires and medical exams, including bloodwork and cardiac echo.

Primary Outcome Measure

Reduced septal e' velocity [ Time Frame: Baseline to 4 years. ]

Central Contacts

Find similar trials

Nationwide
Menopause trialsType 2 diabetes trialsWomen's health trialsFertility trialsEndocrinology trialsMetabolic health trialsWeight loss trials

Related Studies